Search details
1.
TSLP enhances progestin response in endometrial cancer via androgen receptor signal pathway.
Br J Cancer
; 130(4): 585-596, 2024 03.
Article
in English
| MEDLINE | ID: mdl-38172534
2.
Assisted reproductive technology treatment failure and the detection of intrauterine HPV through spent embryo transfer media sample.
J Med Virol
; 96(3): e29468, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38415499
3.
Brusatol sensitizes endometrial hyperplasia and cancer to progestin by suppressing NRF2-TET1-AKR1C1-mediated progestin metabolism.
Lab Invest
; 102(12): 1335-1345, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36038734
4.
ART strategies in Klinefelter syndrome.
J Assist Reprod Genet
; 37(9): 2053-2079, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-32562095
5.
TET1-GPER-PI3K/AKT pathway is involved in insulin-driven endometrial cancer cell proliferation.
Biochem Biophys Res Commun
; 482(4): 857-862, 2017 Jan 22.
Article
in English
| MEDLINE | ID: mdl-27889612
6.
Sex-determining region Y-box3 (SOX3) functions as an oncogene in promoting epithelial ovarian cancer by targeting Src kinase.
Tumour Biol
; 37(9): 12263-12271, 2016 Sep.
Article
in English
| MEDLINE | ID: mdl-27251670
7.
NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
Tumour Biol
; 37(7): 9671-80, 2016 Jul.
Article
in English
| MEDLINE | ID: mdl-26801672
8.
OCT4 mediates FSH-induced epithelial-mesenchymal transition and invasion through the ERK1/2 signaling pathway in epithelial ovarian cancer.
Biochem Biophys Res Commun
; 461(3): 525-32, 2015 Jun 05.
Article
in English
| MEDLINE | ID: mdl-25911324
9.
ATM may be a protective factor in endometrial carcinogenesis with the progesterone pathway.
Tumour Biol
; 36(3): 1529-37, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25608836
10.
Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway.
Int J Gynecol Cancer
; 24(9): 1564-74, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25340291
11.
The protein levels of MCM7 and p63 in evaluating lesion severity of cervical disease.
Int J Gynecol Cancer
; 23(2): 318-24, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23318911
12.
Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment.
Mol Med
; 18: 1197-208, 2012 Oct 24.
Article
in English
| MEDLINE | ID: mdl-22801793
13.
Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression.
J Obstet Gynaecol Res
; 38(8): 1077-85, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-22540333
14.
Oestrogen receptor α mediates 17ß-estradiol enhancement of ovarian cancer cell motility through up-regulation of survivin expression.
Arch Gynecol Obstet
; 286(3): 729-37, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22569715
15.
Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma.
Cancers (Basel)
; 14(24)2022 Dec 15.
Article
in English
| MEDLINE | ID: mdl-36551694
16.
Ovarian stimulation in IVF couples with severe male factor infertility: GnRH antagonist versus long GnRH agonist.
Front Endocrinol (Lausanne)
; 13: 1037220, 2022.
Article
in English
| MEDLINE | ID: mdl-36277710
17.
Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer.
Cancer Sci
; 102(3): 557-64, 2011 Mar.
Article
in English
| MEDLINE | ID: mdl-21205080
18.
Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel.
BMC Cancer
; 11: 22, 2011 Jan 19.
Article
in English
| MEDLINE | ID: mdl-21244707
19.
Metformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expression.
Int J Gynecol Cancer
; 21(2): 213-21, 2011 Feb.
Article
in English
| MEDLINE | ID: mdl-21270604
20.
Snail is critical for tumor growth and metastasis of ovarian carcinoma.
Int J Cancer
; 126(9): 2102-11, 2010 May 01.
Article
in English
| MEDLINE | ID: mdl-19795442